Global, Regional, and National Burden of Heart Failure Associated with Atrial Fibrillation

Overview

Journal BMC Cardiovasc Disord

Publisher Biomed Central

Specialty Cardiology & Vascular Diseases

Date 2023 Jul 10

PMID 37430216

Authors

Sanjeewa Kularatna

Amarzaya Jadambaa

Sumudu Hewage

David Brain

Steven McPhail

William Parsonage

Affiliations

Soon will be listed here.

Abstract

Background: Heart failure is a leading cause of mortality and morbidity worldwide, and Atrial fibrillation (AF) is among many modifiable risk factors for heart failure. No estimates are available on the magnitude of the burden of heart failure associated with AF, and this study estimated the global, regional, and national burdens associated with AF.

Methods: We used the comparative risk assessment method to estimate the disease burden in terms of prevalence and years lived with disability (YLD). The population-attributable fraction for heart failure and AF was calculated from prevalence estimates of AF and the recalculated relative risks of heart failure associated with AF from a systematic review summarising the longitudinal association between AF and outcomes. The burden of heart failure was retrieved from the Global Burden of Disease database.

Results: Globally, 2.6% (95% uncertainty interval 1.3 to 4.7%) of the burden of heart failure is associated with AF. This was 1.5 (95% UI 0.6 to 3.2) million people in 2019, a 49.8% increase from 1990. The highest prevalence was from South-East Asia, East Asia and Oceania. The highest YLD was estimated for Central Europe, Eastern Europe and Central Asia. High-income countries showed a sharp decline in the age standardised prevalence and YLD rates from 1990 to 2019.

Conclusion: The burden of heart failure associated with AF has increased substantially over the past two decades despite the advances in AF management. However, falling prevalence and YLD rates of heart failure associated with AF in high-income countries over time indicate that reducing this burden is possible.

Citing Articles

Traditional Chinese medicine challenging conventional Western medicine in cardiovascular diseases?.

Khalil M, Portincasa P Intern Emerg Med. 2025; .

PMID: 39956848 DOI: 10.1007/s11739-025-03892-9.

Left Atrial Appendage Closure With Catheter Ablation vs. Ablation Alone on Outcomes of Atrial Fibrillation in Heart Failure With Reduced Ejection Fraction: A Propensity Score-Matched Analysis.

Uwumiro F, Oghotuoma O, Eyiah N, Ojukwu S, Uwaoma G, Okpujie V Cureus. 2024; 16(11):e74577.

PMID: 39735150 PMC: 11673331. DOI: 10.7759/cureus.74577.

Artificial intelligence and atrial fibrillation: A bibliometric analysis from 2013 to 2023.

Jia B, Chen J, Luan Y, Wang H, Wei Y, Hu Y Heliyon. 2024; 10(15):e35067.

PMID: 39157317 PMC: 11328043. DOI: 10.1016/j.heliyon.2024.e35067.

References

Ruigomez A, Johansson S, Wallander M, Edvardsson N, Rodriguez L . Risk of cardiovascular and cerebrovascular events after atrial fibrillation diagnosis. Int J Cardiol. 2008; 136(2):186-92. DOI: 10.1016/j.ijcard.2008.04.050. View

Jones N, Taylor C, Hobbs F, Bowman L, Casadei B . Screening for atrial fibrillation: a call for evidence. Eur Heart J. 2019; 41(10):1075-1085. PMC: 7060457. DOI: 10.1093/eurheartj/ehz834. View

Conen D, Chae C, Glynn R, Tedrow U, Everett B, Buring J . Risk of death and cardiovascular events in initially healthy women with new-onset atrial fibrillation. JAMA. 2011; 305(20):2080-7. PMC: 3105776. DOI: 10.1001/jama.2011.659. View

Ruel M, Kapila V, Price J, Kulik A, Burwash I, Mesana T . Natural history and predictors of outcome in patients with concomitant functional mitral regurgitation at the time of aortic valve replacement. Circulation. 2006; 114(1 Suppl):I541-6. DOI: 10.1161/CIRCULATIONAHA.105.000976. View

Braunwald E . Shattuck lecture--cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. N Engl J Med. 1997; 337(19):1360-9. DOI: 10.1056/NEJM199711063371906. View

Stewart S, Hart C, Hole D, McMurray J . A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study. Am J Med. 2002; 113(5):359-64. DOI: 10.1016/s0002-9343(02)01236-6. View

. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of.... Lancet. 2018; 392(10159):1923-1994. PMC: 6227755. DOI: 10.1016/S0140-6736(18)32225-6. View

Wilson J, Douglas P, Hickey W, Lanoce V, Ferraro N, Muhammad A . Experimental congestive heart failure produced by rapid ventricular pacing in the dog: cardiac effects. Circulation. 1987; 75(4):857-67. DOI: 10.1161/01.cir.75.4.857. View

Turakhia M, Shafrin J, Bognar K, Trocio J, Abdulsattar Y, Wiederkehr D . Estimated prevalence of undiagnosed atrial fibrillation in the United States. PLoS One. 2018; 13(4):e0195088. PMC: 5896911. DOI: 10.1371/journal.pone.0195088. View

10.

Doi S, Barendregt J, Mozurkewich E . Meta-analysis of heterogeneous clinical trials: an empirical example. Contemp Clin Trials. 2010; 32(2):288-98. DOI: 10.1016/j.cct.2010.12.006. View

11.

Odutayo A, Wong C, Hsiao A, Hopewell S, Altman D, Emdin C . Atrial fibrillation and risks of cardiovascular disease, renal disease, and death: systematic review and meta-analysis. BMJ. 2016; 354:i4482. DOI: 10.1136/bmj.i4482. View

12.

Armstrong P, Stopps T, Ford S, de Bold A . Rapid ventricular pacing in the dog: pathophysiologic studies of heart failure. Circulation. 1986; 74(5):1075-84. DOI: 10.1161/01.cir.74.5.1075. View

13.

Pega F, Nafradi B, Momen N, Ujita Y, Streicher K, Pruss-Ustun A . Global, regional, and national burdens of ischemic heart disease and stroke attributable to exposure to long working hours for 194 countries, 2000-2016: A systematic analysis from the WHO/ILO Joint Estimates of the Work-related Burden of Disease and.... Environ Int. 2021; 154:106595. PMC: 8204267. DOI: 10.1016/j.envint.2021.106595. View

14.

Kazemian P, Oudit G, Jugdutt B . Atrial fibrillation and heart failure in the elderly. Heart Fail Rev. 2011; 17(4-5):597-613. DOI: 10.1007/s10741-011-9290-y. View

15.

Anter E, Jessup M, Callans D . Atrial fibrillation and heart failure: treatment considerations for a dual epidemic. Circulation. 2009; 119(18):2516-25. DOI: 10.1161/CIRCULATIONAHA.108.821306. View

16.

Zupan I, Rakovec P, Budihna N, Brecelj A, Kozelj M . Tachycardia induced cardiomyopathy in dogs; relation between chronic supraventricular and chronic ventricular tachycardia. Int J Cardiol. 1996; 56(1):75-81. DOI: 10.1016/0167-5273(96)02728-3. View

17.

Andersson T, Magnuson A, Bryngelsson I, Frobert O, Henriksson K, Edvardsson N . Gender-related differences in risk of cardiovascular morbidity and all-cause mortality in patients hospitalized with incident atrial fibrillation without concomitant diseases: a nationwide cohort study of 9519 patients. Int J Cardiol. 2014; 177(1):91-9. DOI: 10.1016/j.ijcard.2014.09.092. View

18.

Wang T, Larson M, Levy D, Vasan R, Leip E, Wolf P . Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study. Circulation. 2003; 107(23):2920-5. DOI: 10.1161/01.CIR.0000072767.89944.6E. View

19.

Hindricks G, Potpara T, Dagres N, Arbelo E, Bax J, Blomstrom-Lundqvist C . 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the.... Eur Heart J. 2020; 42(5):373-498. DOI: 10.1093/eurheartj/ehaa612. View

20.

Smit M, van Dessel P, Nieuwland W, Wiesfeld A, Tan E, Anthonio R . Right ventricular pacing and the risk of heart failure in implantable cardioverter-defibrillator patients. Heart Rhythm. 2006; 3(12):1397-403. DOI: 10.1016/j.hrthm.2006.08.006. View